A Clinical Study in Patients With Chronic Idiopathic Thrombocytopenic Purpura in R788

Summary

The purpose of this study is to investigate the efficacy, safety and pharmacokinetics of R788 compared with placebo, and to investigate the safety and efficacy of long term dosing of R788 in patients with chronic idiopathic thrombocytopenic purpura.

Timeline

Start

2019-12-24

Primary completion

2021-12-21

Completion

2023-09-25

Drugs

Indications